Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas

Comparison Between Clinical Diagnosis and CSF Biomarkers of Alzheimer Disease in Elderly Patients with Late Onset Psychosis: Helsinki Old Age Psychosis Study (HOPS)

(2013) Toni T. Seppälä et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Tumor interstitial fluid — A treasure trove of cancer biomarkers

(2013) Pavel Gromov et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

The Somatic Genomic Landscape of Glioblastoma

(2013) Cameron W. Brennan et al.   CELL

Interleukin-6 is overexpressed and augments invasiveness of human glioma stem cells in vitro

(2013) Bo Qiu et al.   CLINICAL & EXPERIMENTAL METASTASIS

Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience

(2013) J. S. Frenel et al.   JOURNAL OF NEURO-ONCOLOGY

GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients

(2013) Satoshi Nakamizo et al.   JOURNAL OF NEURO-ONCOLOGY

Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types

(2013) Inti Zlobec et al.   Journal of Translational Medicine

Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis

(2013) Y.-W. Kim et al.   NEURO-ONCOLOGY

Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development

(2013) P. Kucharzewska et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells

(2013) Cheryl CY Li et al.   RNA Biology

Interleukins in glioblastoma pathophysiology: implications for therapy

(2012) YT Yeung et al.   BRITISH JOURNAL OF PHARMACOLOGY

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

(2012) Martin J. van den Bent et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognosis of patients with multifocal glioblastoma: a case-control study

(2012) Chirag G. Patil et al.   JOURNAL OF NEUROSURGERY

Identification and proteomic profiling of exosomes in human cerebrospinal fluid

(2012) Jonathan M Street et al.   Journal of Translational Medicine

MS risk genes are transcriptionally regulated in CSF leukocytes at relapse

(2012) Margareta Jernås et al.   Multiple Sclerosis Journal

Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid

(2012) Amanda M. Saratsis et al.   NEURO-ONCOLOGY

High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide era

(2012) Chirag G. Patil et al.   NEURO-ONCOLOGY

Moving toward molecular classification of diffuse gliomas in adults

(2012) B. J. Theeler et al.   NEUROLOGY

Medulloblastoma Exosome Proteomics Yield Functional Roles for Extracellular Vesicles

(2012) Laura M. Epple et al.   PLoS One

Alterations in Cerebrospinal Fluid Proteins in a Presymptomatic Primary Glioma Model

(2012) John C. Whitin et al.   PLoS One

Changes in the expression of proteins associated with aerobic glycolysis and cell migration are involved in tumorigenic ability of two glioma cell lines

(2012) Anelisa Ramão et al.   Proteome Science

Investigation of serum proteome alterations in human glioblastoma multiforme

(2012) Kishore Gollapalli et al.   PROTEOMICS

Improving prognosis of glioblastoma in the 21st century: Who has benefited most?

(2011) Yaacov Richard Lawrence et al.   CANCER

Splicing Factor hnRNP A2/B1 Regulates Tumor Suppressor Gene Splicing and Is an Oncogenic Driver in Glioblastoma

(2011) R. Golan-Gerstl et al.   CANCER RESEARCH

Prognostic Value of Free DNA Quantification in Serum and Cerebrospinal Fluid in Glioma Patients

(2011) Wei Shi et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma

(2011) Ning Bu et al.   JOURNAL OF NEURO-ONCOLOGY

Proteomics of gliomas: Initial biomarker discovery and evolution of technology

(2011) J. Kalinina et al.   NEURO-ONCOLOGY

Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma

(2011) A. Baraniskin et al.   NEURO-ONCOLOGY

Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone

(2010) H. Bartosik-Psujek et al.   ACTA NEUROLOGICA SCANDINAVICA

Wild type p53-dependent transcriptional upregulation of cathepsin L expression is mediated by C/EBPα in human glioblastoma cells

(2010) Rahul Katara et al.   BIOLOGICAL CHEMISTRY

Glioma Pathophysiology: Insights Emerging from Proteomics

(2010) Ruth F. Deighton et al.   BRAIN PATHOLOGY

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer’s disease

(2010) K. Une et al.   EUROPEAN JOURNAL OF NEUROLOGY

Proteomic Identification of Haptoglobin α2 as a Glioblastoma Serum Biomarker: Implications in Cancer Cell Migration and Tumor Growth

(2010) Durairaj Mohan Kumar et al.   JOURNAL OF PROTEOME RESEARCH

Glioma proteomics: Status and perspectives

(2010) Simone P. Niclou et al.   Journal of Proteomics

IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy?

(2010) M. Labussiere et al.   ONCOLOGIST

Downregulated expression of HSP27 in human low-grade glioma tissues discovered by a quantitative proteomic analysis

(2010) Guobo Shen et al.   Proteome Science

Colorectal cancer proteomics, molecular characterization and biomarker discovery

(2010) Rodrigo Barderas et al.   Proteomics Clinical Applications

EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma

(2009) Bryan D. Choi et al.   BRAIN PATHOLOGY

In-Depth Proteomics to Define the Cell Surface and Secretome of Ovarian Cancer Cells and Processes of Protein Shedding

(2009) V. M. Faca et al.   CANCER RESEARCH

Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme

(2009) M.U. Schuhmann et al.   EJSO

Serum proteomics of glioma: methods and applications

(2009) Kumaravel Somasundaram et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

MGMTPromoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

(2009) Martin J. van den Bent et al.   JOURNAL OF CLINICAL ONCOLOGY

Nuclear Factor I Regulates Brain Fatty Acid-Binding Protein and Glial Fibrillary Acidic Protein Gene Expression in Malignant Glioma Cell Lines

(2009) Miranda Brun et al.   JOURNAL OF MOLECULAR BIOLOGY

Multifarious proteomic signatures and regional heterogeneity in glioblastomas

(2009) Chul-Kee Park et al.   JOURNAL OF NEURO-ONCOLOGY

Proteomics of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma: Usefulness of gelsolin protein

(2009) Mihoko Ohnishi et al.   PATHOLOGY INTERNATIONAL

Serum  2-HS Glycoprotein Predicts Survival in Patients with Glioblastoma

(2008) V. Petrik et al.   CLINICAL CHEMISTRY

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

(2008) Roger McLendon et al.   NATURE

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

(2008) Johan Skog et al.   NATURE CELL BIOLOGY

Identification of a novel proliferation-related protein, WHSC1 4a, in human gliomas

(2008) Jie Li et al.   NEURO-ONCOLOGY

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins

(2008) Jiri Petrak et al.   PROTEOMICS